Methodologial quality of the review: Medium confidence
Author: Cheng JW, Cheng SW, Cai, JP, Li Y, Wei RL
Geographical coverage: Not reported
Sector: Glaucoma
Sub-sector: Treatment of open angle glaucoma
Equity focus: None specified
Review type: Effectiveness review
Quantitative synthesis method: Meta-analysis
Qualitative synthesis method: Not applicable
Background: Recently, non-penetrating glaucoma surgeries (NPGS) have been used as they are assumed safer than classic trabeculectomy (TE). However, there have been strong discussions on the efficacy and longevity of NPGS, and the potential of NPGS to achieve target intra-ocular pressure (IOP).
Objectives: To evaluate the IOP-lowering effects achieved by NPGS and its modifications in patients with open angle glaucoma.
Main findings: 29 studies were included in this review. The results at two years showed that deep sclerectomy (DS) and viscocanalostomy (VCO) were less effective than TE in lowering IOP. The IOP was reduced by 35.2%, 30.2% and 45.6% for DS, VCO and TE respectively. Intraoperative use of implants and mitomycin C (MMC) were found to increase IOP-lowering effects of DS by 41.1% and 41.7% respectively.
The complete success rates at four years were 35.4% for DS and 22.7% for VCO, lower than that of TE (47.6%). The complete success rates of DS with implants and MMC of 64.6% and 52.1% respectively at four years were greater than that of primary DS. NPGS caused major complications in fewer patients than did TE.
Overall, authors concluded that DS and VCO can significantly lower IOP with fewer complications than TE. However, their IOP-lowering effect is lower than that of TE. The efficacy of DS can be improved with the intraoperative use of implants and MMC. However, further studies are required to determine the validity, reliability and sensitivity of the target IOP.
Methodology: PUBMED, EMBASE, and the Cochrane Controlled Trials Register were searched for randomised controlled trials (RCTs) using identified search terms. Reference lists of original reports and review articles retrieved through the search were reviewed for additional studies not included in the computerised databases. The searches were conducted independently by two reviewers.
The inclusion criteria were:
(a) Study type: RCTs, including placebo- or active-controlled
(b) Population: all patients with a diagnosis of open angle glaucoma (OAG), including primary and secondary
(c) Intervention: one of all the non-penetrating surgical procedures was undertaken
(d) Outcome variables: at least one of the following outcome variables – percentage of IOP reduction (IOPR) and complete success rates
(e) Duration: follow-up time of not less than six months postoperatively
(f) Publication parameters: written in any language.
The main outcome measures were the percentage IOPR and the complete success rate. Complete success was defined as target endpoint IOP (usually less than 21 mm Hg) without medications.
Data extraction was performed independently by two reviewers using a costumised form. Methodological quality of included studies was evaluated independently by two authors using the Delphi list on a scale from 0 to 20. Authors conducted a pooled analysis, which was calculated using the random-effects model.
Applicability/external validity: The authors did not discuss the applicability/external validity of the results.
Geographic focus: This review focused on all countries. Studies from low/middle-income countries were included.
Summary of quality assessment: Overall, there is medium confidence in the conclusions about the effects of this study. Although authors/experts were not contacted as part of the search strategy, a thorough search of the literature was conducted on relevant databases – avoiding language bias – to ensure that all relevant studies were identified. It is not clear whether authors did not restrict the research to published studies only. Authors used appropriate methods to sift through studies for inclusion, avoiding selection bias, and appropriately extracted data and assessed methodological quality using validated tools.
© 2025 by Sightsavers, Inc., Business Address for all correspondence: One Boston Place, Suite 2600, Boston, MA 02108.
To make sure you have a great experience on our site, we’d like your consent to use cookies. These will collect anonymous statistics to personalise your experience.
You have the option to enable non-essential cookies, which will help us enhance your experience and improve our website.
These enable our site to work correctly, for example by storing page settings. You can disable these by changing your browser settings, but some parts of our website will not work as expected.
To improve our website, we’d like to collect anonymous data about how you use the site, such as which pages you read, the device you’re using, and whether your visit includes a donation. This is completely anonymous, and is never used to profile individual visitors.
To raise awareness about our work, we’d like to show you Sightsavers adverts as you browse the web. By accepting these cookies, our advertising partners may use anonymous information to show you our adverts on other websites you visit. If you do not enable advertising cookies, you will still see adverts on other websites, but they may be less relevant to you. For info, see the Google Ads privacy policy.